InvestorsHub Logo

tpbrogan

06/04/14 4:40 PM

#22160 RE: camvvv #22158

I don't think there is much financial upside to a buyout. Too many OS.

rudygerner

06/04/14 10:09 PM

#22184 RE: camvvv #22158

Buyout is imminent, likely pending FDA approval. Celgene will be the suitor, imho. I take no position as to whether I would prefer a buyout or not. Nuvilex owns proprietary technology on the cusp of FDA approval. Big pharma is lurking just around the corner.